16 juill. 2012 - FDA Approves Truvada
Description:
On July 16, 2012, the U.S. Food and Drug Administration (FDA) approved the use of Truvada® (a fixed dose combination of emtricitabine/tenofovir disoproxil fumarate) as a pre-exposure prophylaxis (PrEP) for HIV-negative individuals who are at high risk of acquiring HIV.Ajouté au bande de temps:
Date:
16 juill. 2012
Maintenaint
~ Il y a 13 ans